Over the 90-day window ending February 19, 2026, Pliant Therapeutics's three dominant insider ownership positions are held by TenPercentOwner Rock Ventures Iii, L.P. Third (1.84Mn shares), President And Ceo Bernard Coulie (914.92K shares), Chief Financial Officer Keith Lamont Cummings (297.21K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Rock Ventures Iii, L.P. Third | 1,839,160 | 01 Dec, 2022 | |
| Bernard Coulie | President And Ceo | 914,918 | 22 Jan, 2026 |
| Keith Lamont Cummings | Chief Financial Officer | 297,214 | 22 Jan, 2026 |
| Hans Hull | Chief Business Officer | 251,708 | 27 Jan, 2025 |
| Eric Lefebvre | Chief Medical Officer | 240,224 | 27 Jan, 2025 |
| Mike Ouimette | General Counsel & Corp. Sec'Y | 105,544 | 27 Jan, 2025 |
| Lily Cheung | Chief Human Resource Officer | 44,847 | 22 Jan, 2026 |
| Minnie Kuo | Chief Operating Officer | 37,806 | 22 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Jan, 2026 | Bernard Coulie | Common Stock | D | 89,375 | $1.28 | 505,601 | D | S |
| 20 Jan, 2026 | Keith Lamont Cummings | Common Stock | D | 24,002 | $1.28 | 297,214 | D | S |
| 20 Jan, 2026 | Lily Cheung | Common Stock | D | 7,534 | $1.28 | 44,847 | D | S |
| 20 Jan, 2026 | Minnie Kuo | Common Stock | D | 6,917 | $1.28 | 37,806 | D | S |
| 23 Jan, 2025 | Eric Lefebvre | Common Stock | A | 45,650 | $0.00 | 240,224 | D | A |
| 23 Jan, 2025 | Hans Hull | - | - | 251,708 | D | |||
| 23 Jan, 2025 | Hans Hull | Common Stock | A | 40,150 | $0.00 | 251,708 | D | A |
| 23 Jan, 2025 | Bernard Coulie | Common Stock | A | 162,500 | $0.00 | 593,017 | D | A |
| 23 Jan, 2025 | Keith Lamont Cummings | Common Stock | A | 56,650 | $0.00 | 319,258 | D | A |
| 23 Jan, 2025 | Mike Ouimette | Common Stock | A | 35,000 | $0.00 | 105,544 | D | A |
| 23 Jan, 2025 | Lily Cheung | Common Stock | A | 25,875 | $0.00 | 50,425 | D | A |
| 22 Jan, 2025 | Mike Ouimette | Common Stock | D | 10,230 | $10.99 | 70,544 | D | S |
| 22 Jan, 2025 | Mike Ouimette | - | - | 70,544 | D | |||
| 17 Jan, 2025 | Eric Lefebvre | Common Stock | D | 18,478 | $11.20 | 194,574 | D | S |
| 17 Jan, 2025 | Hans Hull | Common Stock | D | 15,936 | $11.20 | 211,558 | D | S |
| 17 Jan, 2025 | Bernard Coulie | Common Stock | D | 52,419 | $11.20 | 430,517 | D | S |
| 17 Jan, 2025 | Keith Lamont Cummings | Common Stock | D | 20,148 | $11.20 | 262,608 | D | S |
| 17 Jan, 2025 | Mike Ouimette | Common Stock | D | 13,270 | $11.20 | 80,774 | D | S |
| 17 Jan, 2025 | Mike Ouimette | - | - | 80,774 | D | |||
| 17 Jan, 2025 | Lily Cheung | Common Stock | D | 3,740 | $11.20 | 24,550 | D | S |